Senior insider sale
EVP Research & Development at CYTOKINETICS INC — senior position signals high conviction
$2.57M
37.39K shares
What this filing means
MALIK FADY IBRAHAM plans to sell 37.39K shares of CYTOKINETICS INC valued at approximately $2.57M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/20/2026ACC: 0001950047-26-010332
Officer· EVP Research & Development
Since Jul 2018
37.39K
Shares to sell
$2.57M
Approx. market value
16.39K
Acquired (3 months)
1
Planned
6 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
10/20/2026
16.39KTotal acquired16.39K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/20/2026 | Exercise of Stock Options Cash | 16.39K | — |
| Total | 16.39K | ||
Planned & Completed Dispositions7
Completed
—Completed
Units to sell
3.50K
Market value
$214.8K
10/6/2026
—Completed
Units to sell
3.50K
Market value
$239.0K
9/22/2026
—Completed
Units to sell
3.50K
Market value
$264.1K
9/8/2026
—Completed
Units to sell
3.50K
Market value
$265.4K
8/18/2026
—Completed
Units to sell
3.50K
Market value
$273.9K
8/4/2026
—Completed
Units to sell
3.50K
Market value
$282.1K
7/21/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
16.39K
Market value
$1.03M
10/20/2026
Total
Units
37.39K
Value
$2.57M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
10/6/2026 | 3.50K | $214.8K | — | Completed |
9/22/2026 | 3.50K | $239.0K | — | Completed |
9/8/2026 | 3.50K | $264.1K | — | Completed |
8/18/2026 | 3.50K | $265.4K | — | Completed |
8/4/2026 | 3.50K | $273.9K | — | Completed |
7/21/2026 | 3.50K | $282.1K | — | Completed |
| Planned — Approximate Date | ||||
10/20/2026 | 16.39K | $1.03M | NASDAQ | Planned |
| Total | 37.39K | $2.57M | ||